Fatigue News and Research

RSS

CHOP researchers develop tool to monitor disease severity in patients with mitochondrial myopathy

Researchers at Children's Hospital of Philadelphia successfully developed and validated a new outcome measure to monitor disease severity and progression in patients with impaired skeletal muscle function caused by mitochondrial disease.

1 Sep 2021

Study explores factors that drive older adults to start or sustain physical activity

The importance of physical activity is well recognized by both science and the public. Yet, more than 80 percent of adults in the United States fail to meet the U.S. Centers for Disease Control and Prevention's "Physical Activity Guidelines for Americans," which recommends at least 150 minutes of moderate intensity or 75 minutes of vigorous-intensity physical activity per week. Moreover, 40 percent of Americans over the age of 75 are entirely inactive.

1 Sep 2021

Non-traditional cardiovascular risk factors are rising more steeply among women than men

Work stress, sleep disorders, and fatigue, regarded as non-traditional risk factors for heart attack and stroke, are rising more steeply amongst women than men, according to a new study presented today at the European Stroke Organisation (ESO) Conference.

1 Sep 2021

"FibroCOVID" - An emerging entity

In a recent study, a team of researchers aimed to investigate the prevalence and predictors of fibromyalgia in patients who recovered from COVID-19.

31 Aug 2021

Shorter survival of multiple myeloma subgroup linked to worse kidney damage

Nearly 20% of patients with multiple myeloma have a form in which they make extreme quantities of one component of the abnormal antibody they are producing, and these so-called "free monoclonal light chains" pile up and damage the kidneys, investigators say.

31 Aug 2021

New strategy combining heart failure with depression treatment improves patients' clinical outcomes

A telephone-delivered nursing care strategy that combined heart failure care management with depression treatment improved patients' clinical outcomes, discovered clinicians from the University of Pittsburgh.

31 Aug 2021

Research explores the role of cameras in employee fatigue during virtual meetings

More than a year after the pandemic resulted in many employees shifting to remote work, virtual meetings have become a familiar part of daily life. Along with that may come "Zoom fatigue" – a feeling of being drained and lacking energy following a day of virtual meetings.

31 Aug 2021

Researchers identify 55 lingering effects of COVID-19

As COVID-19 hospitalizations once again soar in a fourth surge more than 18 months after the pandemic started, some patients continue to experience symptoms long after recovering from COVID, according to a Houston Methodist study recently published in Nature's Scientific Reports.

30 Aug 2021

Gitelman syndrome more common in Japanese population than previously reported

Clinical Fellow KONDO Atsushi and Professor NOZU Kandai et al. of Kobe University's Graduate School of Medicine have estimated the prevalence of Gitelman syndrome across different ethnicities using a genome database.

30 Aug 2021

Concert venues are banking on proof of vaccines or negative tests to woo back fans

Fans of the band Wilco could have reasonably interpreted frontman Jeff Tweedy singing "I Am Trying to Break Your Heart" at an Aug. 13 concert at St. Louis Music Park as the universe explaining the past year or so.

30 Aug 2021

Have SARS-CoV-2 symptoms changed in the UK population over time?

A new paper compares changes in the symptoms due to COVID-19 over the course of the pandemic.

29 Aug 2021

$Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction$

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.

28 Aug 2021

Researchers analyze dynamic changes in chest CT images over 167 days in 11 COVID-19 patients

Announcing a new article publication for Zoonoses journal. In this article the authors Jianqin Liang, Guizeng Liu, Shuzhuang Yu, Yang Yang, Yanchun Li, Hongli Tian, Zhe Chen and Wenping Gong The Eighth Medical Center of PLA General Hospital, Beijing, China and Nanpi County People's Hospital, Hebei, China discuss dynamic changes in chest CT images over 167 days in 11 patients with COVID-19.

28 Aug 2021

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.

28 Aug 2021

Ultrasound-based technology for measuring brain pressure could replace surgery

A new invention may be on the verge of replacing a costly cranial surgical procedure currently being performed on some traffic accident victims and other patient groups. The ultrasound-based technology has now been granted CE approval for the European market.

28 Aug 2021

FDA approves drug-free stroke rehabilitation system to treat upper extremity motor deficits

The U.S. Food and Drug Administration today approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke—a stroke caused by a blockage of blood flow to the brain with long-lasting symptoms—using vagus nerve stimulation (VNS).

27 Aug 2021

Study: One half of hospitalized COVID-19 patients experience persistent symptoms after one year

Most symptoms of COVID-19 in hospitalized patients are resolved within 12 months, however, around one half still experience at least one persistent symptom, a study of 1,276 patients from Wuhan, China, published in The Lancet, has found.

27 Aug 2021

Review highlights similarities between long COVID and chronic fatigue syndrome

A team of researchers, including two from Johns Hopkins Medicine, have published a review article highlighting similarities between certain lingering symptoms following COVID-19 illness — a condition called "long COVID" — and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating, complex disorder previously known as chronic fatigue syndrome.

26 Aug 2021

Two mRNA vaccines are effective even without post-shot symptoms or prior SARS-CoV-2 infection

Vaccination with the two messenger RNA (mRNA) vaccines for SARS-CoV-2, the virus that causes COVID-19, yields a robust antibody response, even if a person did not develop significant symptoms following vaccination or did not have a prior SARS-CoV-2 infection.

26 Aug 2021

AHA special issue focuses on health disparities among racial, ethnic communities

Poverty and Black race were associated with higher rates of lower leg amputation among people with peripheral artery disease who live in metropolitan areas, according to new research published today in a special issue of the Journal of the American Heart Association, an open access journal of the American Heart Association.

25 Aug 2021

Fatigue News and Research

CHOP researchers develop tool to monitor disease severity in patients with mitochondrial myopathy

Study explores factors that drive older adults to start or sustain physical activity

Non-traditional cardiovascular risk factors are rising more steeply among women than men

"FibroCOVID" - An emerging entity

Shorter survival of multiple myeloma subgroup linked to worse kidney damage

New strategy combining heart failure with depression treatment improves patients' clinical outcomes

Research explores the role of cameras in employee fatigue during virtual meetings

Researchers identify 55 lingering effects of COVID-19

Gitelman syndrome more common in Japanese population than previously reported

Concert venues are banking on proof of vaccines or negative tests to woo back fans

Have SARS-CoV-2 symptoms changed in the UK population over time?

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

Researchers analyze dynamic changes in chest CT images over 167 days in 11 COVID-19 patients

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

Ultrasound-based technology for measuring brain pressure could replace surgery

FDA approves drug-free stroke rehabilitation system to treat upper extremity motor deficits

Study: One half of hospitalized COVID-19 patients experience persistent symptoms after one year

Review highlights similarities between long COVID and chronic fatigue syndrome

Two mRNA vaccines are effective even without post-shot symptoms or prior SARS-CoV-2 infection

AHA special issue focuses on health disparities among racial, ethnic communities

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News